Clavis Pharma ASA;Governors of the University of Alberta
发明人:
Sandvold, Marit Liland,Cass, Carol E.,Young, James D.,Myhren, Finn
申请号：
AU2011266705
公开号：
AU2011266705A1
申请日:
2011.06.16
申请国别(地区):
AU
年份:
2012
代理人:
摘要：
This invention provides monoclonal antibodies that recognize hENTl. The invention further provides methods of using such monoclonal antibodies as a therapeutic, diagnostic, and/or prophylactic in disorders associated with aberrant hENTl expression and/or activity.
